It will be important to determine if post-translational modifications such as N-glycosylation are impaired in Type II diabetes, and whether this results in a reduction in cell surface GIPR and GLP-1R number along with the decreased incretin response of the ß-cell. This evidence concerns the gene GCG and type 2 diabetes mellitus.